Heat Biologics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
3 Micro Cap Stocks That Are Worth Looking Into
Article By: Modest Money
Tuesday, October 17, 2017 2:30 PM EST
The best way to invest in micro caps is through an ETF or mutual fund so that you can limit potential risk.
In this article: FLL, HTBX, GNUS
Read
Heat Biologics (HTBX) Surges 30% On Investor Optimism
Article By: AO Markets
Tuesday, November 29, 2016 3:00 AM EST
Heat Biologics surged as much as 30% on Friday on increased investor optimism for trial results set to come out within the next few weeks. Results from its bladder cancer study will be released on November 30.
In this article: HTBX
Read
Heat Biologics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, July 21, 2016 3:40 PM EST
Heat Biologics, Inc. announced today that it has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by Heat.
In this article: HTBX
Read
OncoSec Medical And Heat Biologics Collaborate On Immunotherapy Platforms
Article By: Terry Chrisomalis
Wednesday, February 18, 2015 6:58 PM EST
Oncosec and Heat Biologics form a collaboration deal to run pre-clinical trials in the coming months.
In this article: ONCS, HTBX, INO
Read
Depomed To Acquire U.S. Rights To NUCYNTA®, NUCYNTA® ER; Amgen Presents First-Line Use Of Vectibix®
Article By: BioMedReports
Friday, January 16, 2015 3:44 AM EST
Depomed Inc. announced it has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals, Inc. for $1.05 billion.
In this article: DEPO, AMGN, DDD, ADXS, ALDX, AMBS, AMED, BSDM, BMRN, CBMG, DVCR, GALE, GB, HTBX, HEB, ISRG, OMED, PMCB, PRGB, RGDX, TGTX, WCUI
Read

PARTNER HEADLINES

Latest Tweets for $HTBX

No tweets yet!